# At What Time Therapeutic Plasma Concentrations of Paracetamol Are Achieved in Two Marketed Formulations

> **NCT01551836** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 12 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** Paracetamol formulation 1
- **DRUG:** Paracetamol formulation 2

## Key facts

- **NCT ID:** NCT01551836
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2009-06
- **Final completion:** 2009-06
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2012-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01551836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01551836, "At What Time Therapeutic Plasma Concentrations of Paracetamol Are Achieved in Two Marketed Formulations". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01551836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*